| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
865,460 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,326 |
485,736 |
| Total Sell Value |
$0 |
$0 |
$8,245,949 |
$88,282,436 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
18 |
71 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Baker Julian |
Director |
– • • |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
I/I |
5,926 |
45,842,649 |
|
- |
|
| Simonian Nancy A |
Director |
– • – |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,963 |
24,763 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,963 |
40,168 |
|
- |
|
| Welch Daniel G |
Director |
– • – |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,963 |
72,763 |
|
- |
|
| Seth Alpna |
Director |
– • – |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,963 |
8,713 |
|
- |
|
| Orwin John A |
Director |
– • – |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,963 |
24,763 |
|
- |
|
| Taylor Robin G |
Chief Commercial Officer |
• – – |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
28,298 |
28,298 |
|
- |
|
| Gryska David W |
Director |
– • – |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,963 |
48,013 |
|
- |
|
| Lippman Marc E |
Director |
– • – |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,963 |
131,313 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2019-05-09 |
4 |
AS |
$66.93 |
$325,301 |
D/D |
(4,824) |
749,169 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2019-05-09 |
4 |
OE |
$12.16 |
$58,660 |
D/D |
4,824 |
751,099 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2019-05-08 |
4 |
AS |
$67.41 |
$1,046,066 |
D/D |
(15,324) |
749,169 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2019-05-08 |
4 |
OE |
$12.16 |
$186,340 |
D/D |
15,324 |
750,762 |
|
- |
|
| Baker Julian |
Director |
– • • |
2019-04-29 |
4 |
OE |
$8.38 |
$167,600 |
I/I |
20,000 |
45,839,686 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2019-04-08 |
4 |
AS |
$78.00 |
$1,596,100 |
D/D |
(20,148) |
749,169 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2019-04-08 |
4 |
OE |
$12.16 |
$245,000 |
D/D |
20,148 |
751,969 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2019-04-05 |
4 |
AS |
$78.00 |
$975,000 |
D/D |
(12,500) |
171,780 |
|
- |
|
| Gryska David W |
Director |
– • – |
2019-04-01 |
4 |
AS |
$73.38 |
$367,030 |
D/D |
(5,000) |
45,050 |
|
- |
|
| Gryska David W |
Director |
– • – |
2019-04-01 |
4 |
OE |
$12.76 |
$63,800 |
D/D |
5,000 |
50,050 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2019-03-18 |
4 |
OE |
$12.00 |
$199,988 |
D/D |
16,556 |
749,169 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2019-03-08 |
4 |
AS |
$68.86 |
$1,394,094 |
D/D |
(20,148) |
732,613 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2019-03-08 |
4 |
OE |
$12.16 |
$245,000 |
D/D |
20,148 |
740,115 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2019-03-08 |
4 |
AS |
$68.48 |
$549,746 |
D/D |
(8,000) |
177,329 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2019-03-08 |
4 |
OE |
$12.00 |
$96,000 |
D/D |
8,000 |
185,329 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2019-03-04 |
4 |
AS |
$75.00 |
$750,000 |
D/D |
(10,000) |
184,280 |
|
- |
|
1805 Records found
|
|
Page 21 of 73 |
|
|
